Dietary macromolecules in the intestinal lumen

Dietary macromolecules in the intestinal lumen consist of the primary nutritional components of the diet—carbohydrates, lipids, and proteins—that must be enzymatically hydrolyzed into smaller units before absorption (NCBI Bookshelf, 2022). While these macromolecules are not biological targets in the traditional sense, such as receptors or ion channels, they are the substrates for the digestive enzymes that are targeted by various pharmacological interventions. For instance, pancreatic lipase is inhibited by Orlistat to prevent the breakdown of triglycerides into absorbable free fatty acids and monoglycerides (StatPearls, 2023). Similarly, alpha-glucosidase inhibitors like Acarbose target the enzymes responsible for cleaving complex carbohydrates into glucose, thereby slowing carbohydrate absorption and reducing postprandial hyperglycemia (StatPearls, 2023). These interventions are primarily utilized in the management of metabolic conditions like obesity and type 2 diabetes. However, the presence of undigested macromolecules in the distal small intestine and colon can lead to significant gastrointestinal side effects, including osmotic diarrhea and flatulence due to microbial fermentation (PubMed, 2021).

Other names

Dietary nutrientsIntestinal substratesFood-derived macromoleculesLuminal nutrients

Inhibition of enzymatic hydrolysis (e.g., lipase or alpha-glucosidase inhibition) and physical sequestration of macromolecules or their digestive byproducts to prevent intestinal absorption (StatPearls, 2023).